What is the current price and short-term outlook for AIML.CN stock?

AIML.CN stock trades at **C$0.035** (CNQ) and fell **12.50%** on 18 Feb 2026. Short-term outlook shows possible bounce to **C$0.04** but higher risk if volume stays thin. Meyka forecasts monthly **C$0.02**.

What grade does Meyka AI give AIML.CN stock and what does it mean?

Meyka AI rates AIML.CN **62.08/100 (Grade B)** with a HOLD suggestion. The grade weighs benchmarks, sector, growth, metrics, and analyst consensus. It is informational and not investment advice.

What are realistic price targets for AIML.CN stock?

Realistic scenario targets: conservative **C$0.02** (bear), base **C$0.04**, and constructive **C$0.06** (bull). Targets reflect liquidity, revenue runway, and product milestones and are not guaranteed.

How risky is AIML.CN stock for AI healthcare investors?

AIML.CN stock is high risk due to low market cap **C$6,730,560**, negative EPS, thin volume, and stretched valuation ratios. Positive catalyst could swing price quickly, so manage position sizes carefully.

CA Stocks

AIML.CN (AI/ML Innovations Inc. CNQ) down 12.50% to C$0.035 18 Feb 2026: Meyka warns

ByHuzaifa Zahoor February 18, 2026

AIML.CN stock opened the Canada CNQ session under pressure and fell 12.50% to C$0.035 on 18 Feb 2026 on heavier intraday selling. Trading volume reached 383,020 shares versus an average of 388,552, pushing price near the year low C$0.03. The short-term move follows weak fundamental and liquidity metrics, including a market cap of C$6,730,560, EPS of -0.03, and a negative PE of -1.33. Investors focused on AI and healthcare software should weigh the stock’s technical bounce potential against clear valuation and cash-flow risks.